ReShape Lifesciences Inc [NASDAQ: RSLS] surged by $0.28 during the normal trading session on while it closed the day at $1.36.
ReShape Lifesciences Inc stock has also loss -49.72% of its value over the past 7 days. However, RSLS stock has declined by -73.69% in the 3 months of the year. Over the past six months meanwhile, it has lost -86.92% and lost -69.51% year-on date.
The market cap for RSLS stock reached $0.99 million, with 0.70 million shares outstanding and 0.69 million shares in the current float. Compared to the average trading volume of 159.17K shares, RSLS reached a trading volume of 37490772 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about ReShape Lifesciences Inc [RSLS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RSLS shares is $58.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RSLS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for ReShape Lifesciences Inc is set at 0.45, with the Price to Sales ratio for RSLS stock in the period of the last 12 months amounting to 0.12. The Price to Book ratio for the last quarter was 0.64, with the Price to Cash per share for the same quarter was set at 1.15.
RSLS stock trade performance evaluation
ReShape Lifesciences Inc [RSLS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -49.72. With this latest performance, RSLS shares dropped by -69.91% in over the last four-week period, additionally sinking by -86.92% over the last 6 months – not to mention a drop of -86.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RSLS stock in for the last two-week period is set at 20.56, with the RSI for the last a single of trading hit 17.95, and the three-weeks RSI is set at 23.95 for ReShape Lifesciences Inc [RSLS]. The present Moving Average for the last 50 days of trading for this stock 4.0925, while it was recorded at 2.0192 for the last single week of trading, and 7.8634 for the last 200 days.
ReShape Lifesciences Inc [RSLS]: An insightful look at the core fundamentals
ReShape Lifesciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 1.33.
